Rhabdoid tumor
MONDO:0002728An aggressive malignant embryonal neoplasm usually occurring during childhood. It is characterized by the presence of large cells with abundant cytoplasm, large eccentric nucleus, and a prominent nucleolus and it is associated with abnormalities of chromosome 22. It can arise from the central nervous system, kidney, and the soft tissues. The prognosis is poor.
Also known as: malignant rhabdoid tumor, rhabdoid sarcoma, rhabdoid tumor, rhabdoid cancer
2894 clinical trials for this condition and its sub-types, 63 tagged with Rhabdoid tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Rhabdoid tumor
-
Atypical teratoid rhabdoid tumor 35 trials · 36 incl. sub-types
1 sub-type
-
Rhabdoid tumor of the kidney 7 trials
-
Extrarenal rhabdoid tumor 1 trial
-
Familial rhabdoid tumor 0 trials · 1 incl. sub-types
2 sub-types
-
Striated muscle rhabdoid tumor 0 trials
-
New proton therapy spares spine growth in kids with brain cancer
Disease control Not yet recruitingThis study looks at a new way to give radiation to children with brain tumors that need whole-brain and whole-spine treatment. The technique, called vertebral body-sparing proton therapy, aims to protect the front of the spine bones to preserve bone marrow and growth. Researchers…
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Engineered immune cells take on deadly childhood brain cancer
Disease control Not yet recruitingThis early-stage trial tests a new treatment for children with a rare, aggressive brain tumor called ATRT that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified in a lab to better recognize and attack the tumor, plus a…
Phase 1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for kids with tough brain cancers: experimental drug trial launches
Disease control Not yet recruitingThis early-stage study tests an experimental drug called gallium maltolate in 15 children whose high-grade glioma or atypical teratoid rhabdoid tumor has returned or not responded to treatment. The main goals are to find safe doses and understand side effects. Everyone receives t…
Phase 1 • Sponsor: Sarah Rumler • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC